Allergy Thera. Regulatory News (AGY)

Name of applicant:

ALLERGY THERAPEUTICS PLC

Name of scheme:

Allergy Therapeutics plc 2013 Long Term Incentive Plan 

Period of return:

From:

1 February 2022

To:

31 July 2022

Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:

10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017

Balance of unallotted securities under scheme(s) from previous return:

7,118,772

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period:

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

7,118,772

Name of contact:

Sara Goldsbrough

Telephone number of contact:

+44 (0) 7966 165719